-transparent.png){kind=logo}
We report a case of Hodgkin disease presenting with a subacute myelopathy without evidence of metastatic involvement of the spinal cord. The systemic disease responded to conventional chemotherapy, but the myelopathy only improved after intrathecal dexamethasone was added to the treatment program, beta-2-microglobulin levels in the cerebrospinal fluid were elevated at presentation. Following the use of intrathecal corticosteroids there was a decrease of CSF beta-2-microglobulin levels. The possible significance of these findings is discussed.
Related Publications
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
August 1983,
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
November 1976,
La Nouvelle presse medicale,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
April 2007,
Leukemia & lymphoma,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
January 1998,
Journal of neuro-oncology,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
November 1994,
Internal medicine (Tokyo, Japan),
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
January 1975,
The American journal of the medical sciences,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
January 1984,
Head & neck surgery,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
January 1990,
Haematologica,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
June 2013,
BMJ case reports,
R D Dansey, and
G D Hammond-Tooke, and
K Lai, and
W R Bezwoda
November 2018,
ANZ journal of surgery,
